Cronos Group is a Canadian cannabis company that cultivates, manufactures and sells cannabis flower, extracts and branded consumer products. It operates primarily in Canada’s regulated adult-use and medical markets and has pursued selective international opportunities. A defining feature is Altria’s significant equity stake, which has shaped its capital base and strategic positioning among large cannabis peers.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 33.5 | — | -39.7 | — |
| Q3 2025 | 36.3 | — | 26 | — |
| Q4 2025 | 44.5 | — | -1.8 | — |
| Q1 2026 | 45.2 | — | 13.8 | — |
| Q2 2026 | 53 | 58.4% | 32.1 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Taysha Gene Therapies, Inc. (TSHA), Jefferson Capital, Inc. (JCAP), Omeros Corporation (OMER), Harmonic Inc. (HLIT), Digital Turbine, Inc. (APPS), D-Market Elektronik Hizmetler ve Ticaret A.S. (HEPS)